OmniAb, Inc.

OABI

$4.75

-5.75%

N/A-$0.29

Healthcare

Biotechnology

NASDAQ

Active Trading

OmniAb, Inc. is an American biotechnology firm focused on pioneering therapeutic antibody discovery. The company provides a sophisticated platform that allows its ...

Historical Employee Count of OABI

Current

Change

-21.93%

Minimum

Maximum

114

Recent Filings

Report Date	Employees	Form Type	Filing Date	SEC Filing
Dec 31, 2025	89	10-K	Mar 4, 2026	View
Dec 31, 2024	114	10-K	Mar 18, 2025	View
Dec 31, 2023	106	10-K	Mar 25, 2024	View
Dec 31, 2022	95	10-K	Mar 30, 2023	View
Dec 31, 2021	0	10-K	Mar 28, 2022	View

Supply Chain of OABI

Upstream / Downstream / Proxies

Upstream

GenScript Biotech CorporationHKEx:1548 Ligand Pharmaceuticals IncorporatedNASDAQ:LGNDContract Research Organization Network (US, Europe, Asia)Laboratory Animal Breeding & Production FacilitiesThermo Fisher Scientific Inc.NYSE:TMO Illumina, Inc.NASDAQ:ILMN 10x Genomics, Inc.NASDAQ:TXG Bio-Rad Laboratories, Inc.NYSE:BIO Danaher Corporation (Cytiva)NYSE:DHR Charles River Laboratories International, Inc.NYSE:CRL Revvity, Inc. (f/k/a PerkinElmer) — BioLegendNYSE:RVTY

Downstream

Janssen Pharmaceuticals (Johnson & Johnson)NYSE:JNJTakeda Pharmaceutical Company LimitedTSE:4502Gilead Sciences, Inc.NASDAQ:GILD Sanofi S.A.NASDAQ:SNYServierBaxter International Inc.NYSE:BAX Amgen Inc.NASDAQ:AMGN Merck & Co., Inc.NYSE:MRK Pfizer Inc.NYSE:PFE AbbVie Inc.NYSE:ABBVRoche Holding AG (Genentech)SWX:ROGBristol Myers Squibb CompanyNYSE:BMYNovartis AGSWX:NOVNDana-Farber Cancer InstituteMabtrx BiosciencesWyss Institute for Biologically Inspired Engineering (Harvard University)ArrowMark Partners / Viking Global Investors (NewCo)GenScript Biotech CorporationHKEx:1548

Proxies

AbCellera Biologics Inc.NASDAQ:ABCL Regeneron Pharmaceuticals, Inc.NASDAQ:REGN Ligand Pharmaceuticals IncorporatedNASDAQ:LGND Genmab A/SNASDAQ:GMAB

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer